Form 4 for GILD Gilead Sciences
Accepted 2024-08-12 00:00:00 ET · period of report 2024-08-10 · accession 0001127602-24-022009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-12 | 2024-08-10 | GILD | Patterson Sandra | SVP, Controllership | F - Tax | $73.66 | -980 | 36.0K | -3% | -$72.2K |
| D | 2024-08-12 | 2024-08-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | +3,678 | 37.0K | +11% | — |
| D | 2024-08-12 | 2024-08-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | -3,678 | 14.1K | -21% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-10 | F | D | 980 | $73.66 | 35,976 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-10 | M | A | 3,678 | — | 36,956 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2024-08-10 | M | D | 3,678 | — | 14,084 | D | — · — to — | 3,678 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. |